Literature DB >> 21508153

Sensitivity to isoniazid of Mycobacterium bovis BCG strains and BCG disseminated disease isolates.

Kristopher Kolibab, Steven C Derrick, Sheldon L Morris.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21508153      PMCID： PMC3122778          DOI： 10.1128/JCM.00648-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  8 in total

Review 1.  Multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis: epidemiology and control.

Authors:  Alberto Matteelli; Giovanni Battista Migliori; Daniela Cirillo; Rosella Centis; Enrico Girard; Mario Raviglion
Journal:  Expert Rev Anti Infect Ther       Date:  2007-10       Impact factor: 5.091

2.  A point mutation in the mma3 gene is responsible for impaired methoxymycolic acid production in Mycobacterium bovis BCG strains obtained after 1927.

Authors:  M A Behr; B G Schroeder; J N Brinkman; R A Slayden; C E Barry
Journal:  J Bacteriol       Date:  2000-06       Impact factor: 3.490

3.  Mycobacterium bovis BCG causing vertebral osteomyelitis (Pott's disease) following intravesical BCG therapy.

Authors:  I S Aljada; J K Crane; N Corriere; D G Wagle; D Amsterdam
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

Review 4.  Extensively drug-resistant tuberculosis.

Authors:  Philip LoBue
Journal:  Curr Opin Infect Dis       Date:  2009-04       Impact factor: 4.915

Review 5.  Laboratory diagnostic aspects of drug resistant tuberculosis.

Authors:  Linda M Parsons; Akos Somoskövi; Richard Urbanczik; Max Salfinger
Journal:  Front Biosci       Date:  2004-09-01

6.  Four cases of disseminated Mycobacterium bovis infection following intravesical BCG instillation for treatment of bladder carcinoma.

Authors:  Krisztina A Nadasy; Rikin S Patel; Michael Emmett; Ricardo A Murillo; Marc A Tribble; Robert D Black; William L Sutker
Journal:  South Med J       Date:  2008-01       Impact factor: 0.954

Review 7.  Intravesical therapy for superficial bladder cancer: a systematic review of randomised trials and meta-analyses.

Authors:  Mike D Shelley; Malcolm D Mason; Howard Kynaston
Journal:  Cancer Treat Rev       Date:  2010-01-15       Impact factor: 12.111

8.  Drug therapy of bacillus Calmette-Guérin sepsis.

Authors:  S C Koukol; J I DeHaven; D R Riggs; D L Lamm
Journal:  Urol Res       Date:  1995
  8 in total
  5 in total

Review 1.  Importance of the genetic diversity within the Mycobacterium tuberculosis complex for the development of novel antibiotics and diagnostic tests of drug resistance.

Authors:  Claudio U Köser; Silke Feuerriegel; David K Summers; John A C Archer; Stefan Niemann
Journal:  Antimicrob Agents Chemother       Date:  2012-09-24       Impact factor: 5.191

2.  CLINICAL MANAGEMENT OF LOCALIZED BCG ADVERSE EVENTS IN CHILDREN.

Authors:  Thais das Neves Fraga Moreira; Maria Isabel de Moraes-Pinto; Beatriz Tavares Costa-Carvalho; Anete Sevciovic Grumach; Lily Yin Weckx
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2016-11-03       Impact factor: 1.846

3.  Clinical and laboratory observation of Bacillus Calmette-Guérin infections.

Authors:  Shuihua Lu; Tao Li; Xiuhong Xi; Qingguo Chen; Xuhui Liu
Journal:  Int J Clin Exp Med       Date:  2015-06-15

4.  Genomic expression catalogue of a global collection of BCG vaccine strains show evidence for highly diverged metabolic and cell-wall adaptations.

Authors:  Abdallah M Abdallah; Grant A Hill-Cawthorne; Thomas D Otto; Francesc Coll; José Afonso Guerra-Assunção; Ge Gao; Raeece Naeem; Hifzur Ansari; Tareq B Malas; Sabir A Adroub; Theo Verboom; Roy Ummels; Huoming Zhang; Aswini Kumar Panigrahi; Ruth McNerney; Roland Brosch; Taane G Clark; Marcel A Behr; Wilbert Bitter; Arnab Pain
Journal:  Sci Rep       Date:  2015-10-21       Impact factor: 4.379

5.  Tuberculosis in infants: a retrospective study in China.

Authors:  Ruo-Lin Li; Jun-Li Wang; Xin-Feng Wang; Mao-Shui Wang
Journal:  Springerplus       Date:  2016-04-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.